Community-Acquired Bacterial Pneumonia (CABP) Treatment Market

Starting at US$ 5000

Buy Now

Key Players

  • Actavis Generics
  • Allergan plc
  • Combioxin
  • Cubist Pharmaceuticals LLC (Merck)
  • Cumberland Pharmaceuticals Inc
  • Eagle Pharmaceutical Inc
  • Melinta Therapeutics
  • Merck Sharp & Dohme Corp
  • Nabriva Therapeutics plc
  • Paratek Pharmaceuticals
  • The Vanguard Group
  • Shionogi & Co. Ltd
  • Takeda
  • Theravance Biopharma Inc
  • TiGenix
  • Wakunaga Pharmaceutical Co. Ltd
Future Market Insights

Community-Acquired Bacterial Pneumonia (CABP) Treatment Market